Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

Market Cap	13.54B
Revenue (ttm)	1.80B
Net Income (ttm)	348.47M
Shares Out	175.25M
EPS (ttm)	2.00
PE Ratio	38.69
Forward PE	n/a
Dividend	2.03 (2.63%)
Ex-Dividend Date	Oct 16, 2024

Volume	8,748,604
Average Volume	7,876,088
Open	77.20
Previous Close	79.00
Day's Range	77.01 - 81.30
52-Week Range	64.88 - 214.36
Beta	0.18
RSI	54.26
Earnings Date	Apr 22, 2025

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China. The company develops ophthalmic anti-infective drugs, other ophthalmic drugs, nonsteroidal anti-inflammatory drugs for ophthalmology, mydriatic and ciliary muscle paralytic drugs, ophthalmic anti-inflammatory/anti-infective compound drugs, dry eye products, miotic and anti-glaucoma drugs, and other drugs. It also develops products, such as Zirun, a Cyclosporine eye drops; Sugaojie, a calf bl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1977
• Employees: 1,995
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300573

Financial Performance

In 2023, SHE:300573's revenue was 1.47 billion, an increase of 17.42% compared to the previous year's 1.25 billion. Earnings were 240.04 million, an increase of 13.39%.